Markets

Insider Trading

Hedge Funds

Retirement

Opinion

1281292 - 11759070 - 1

12 Most Advanced Countries in Biotechnology

In this article, we take a look at the 12 most advanced countries in biotechnology. You can skip our detailed analysis of the sector and go directly to 5 Most Advanced Countries in Biotechnology.

The Covid-19 pandemic has awoken the world to its vulnerability to airborne viruses whose outbreaks are extremely hard to contain. It certainly wasn’t the last pandemic, as a Nature study shows how loss of biodiversity is likely to increase the frequency of viral outbreaks. 

However, the pandemic was also an occasion that showcased the global biotechnological capability, as Covid vaccines were developed and rolled out within two years, allowing a return to normalcy.

How Big Data and AI are Transforming Biotechnology

Biotechnology, in comparison to many technological fields, is progressing rapidly. Thanks, in part, to AI. In many ways, the field’s progress has been massively boosted by Machine Learning (ML). For example, ML is increasingly being used for protein folding, an important step involved in drug discovery.

Recently, DeepMind, a UK-based AI subsidiary owned by Alphabet Inc. (NASDAQ:GOOG), announced its deep learning program called AlphaFold, which has solved 98.5% of human proteins’ structures. Prior to AlphaFold, the structure of only 17% of human proteins had been solved and it had been a challenge for half a century. 

Other Deep Learning techniques, such as image classification, are increasingly being adopted to detect cancer from medical scans among many other examples of AI in biotechnology. Deep Learning neural networks and big data have also proved to be highly effective in personalized medicine.

Benchsci, a provider of AI health technologies, has tracked the growth of biotechnology startups adopting Machine Learning technologies  and has shown that as of 2021, 230 biotechnology startups are using AI in the solutions they provide across the world. Some of the prominent startups in the industry include Ampilon, BioSymetrics, 3BIGS, BioRelate and Causaly. 

Big Players

Some of the top market players in the biotechnology industry include Eli Lilly and Company (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Merck & Co., Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), BioNTech SE (NASDAQ:BNTX), argenx SE (NASDAQ:ARGX) and Galapagos NV (NASDAQ:GLPG).

Pfizer Inc. (NYSE:PFE), BioNTech SE (NASDAQ:BNTX) and Merck & Co., Inc. (NYSE:MRK) are known for significant contributions in helping solve recent disease outbreaks, with vaccines.

Other Biotechnology Trends to Watch in 2023

Another often overlooked but highly lucrative emerging field in biotechnology is the artificial meat industry. The meat and dairy industry’s carbon footprint is leading to a demand for artificial meat/dairy products. Its technology has been pioneered through stem cell research. Some leading US startups in this domain include Memphis Meats, New Age Meats and Finless Foods.

Industry Outlook: 2030

According to Grand View Research, the biotechnology industry is valued at $1 trillion as of 2021. The value is projected to reach nearly $4 trillion in 2030, with a CAGR of 14%

The cultured-meat sub-industry, on the other hand, is in its early phase and is valued at $600 million, going by their funding in 2020 and 2021. McKinsey estimates that the market value of lab-grown meat will reach $25 billion in 2030, as consumer acceptance gradually takes hold. Lab grown meat could account for 0.5% of the global meat supply by that time. 

Some of the top countries in terms of research in biotechnology include Singapore, Sweden, United States, United Kingdom and Germany. 

Below, we list the 12 most advanced countries in biotechnology.

Our Methodology

For our list of the 12 most advanced countries in biotechnology, we’ve ranked them based on a Nature study that evaluated the advancement of biotechnology in different countries based on important factors. 

The first factor was ‘public biotechnology’ that evaluated publicly listed biotech companies. Another pillar is focused on education and considers countries’ efforts in biotech fields in academia, like the number of degrees and students. The last pillar is centered around R&D investments in the biotechnology industry. 

To supplement our list of 12 most advanced countries in biotechnology, we’ve gathered the data from various other credible sources like Labio Tech and Tracxn for the number of companies and startups. 

Let’s dive in.

12. Austria

Number of Biotechnology Companies: 900+

Austria is located in the Southern zone of Central Europe. It is home to over 900 biotechnology companies. The country has over 2,400 researchers in the field working in 55 facilities and is home to 77,000 biotechnology students. 

According to Austrian Biotech, a go-to database for biotechnology in the country, 11.2% of the companies in the biotechnology sector are primarily involved in contract-based Research and Development. 

On the other hand, 22.5% are involved in Diagnostics and Analytical services. Another 27.4% are involved in Therapeutics. Some of the top biotechnology companies working on frontier biotechnologies include Phagomed, which develops viral treatments for bacterial infections and F2G, which develops novel treatments for fungal infections.

11. Germany

Number of Biotechnology Companies: 774+

Germany is one of the most advanced countries in biotechnology. It is overall a highly advanced nation in Europe. In terms of Knowledge-and-Technology-Intensive (KTI) industries, Germany contributed 6% to the overall global KTI output in 2019.

The number of biotechnology companies in the county has grown to over 774 as of 2021. As far as academia goes, there are 36 different biotechnology degrees offered in 33 universities in Germany, per Erudera.  

One of the most prominent biotechnology companies in Germany is BioNTech SE (NASDAQ:BNTX), which, as mentioned earlier, was involved in the development of the Pfizer-BioNTech vaccine for Covid-19, in collaboration with the American corporation Pfizer Inc. (NYSE:PFE).

10. Belgium

Number of Biotechnology Companies: 140+

Belgium is located in Northwestern Europe. It has over 140 biotechnology companies as of 2021, according to the leading Biotech news platform, Labio Tech. 

Belgian corporations account for almost 24% of the overall stock value of all biotechnology companies in Europe according to Flanders Investment and Trade. Its top players include argenx SE (NASDAQ:ARGX) and Galapagos NV (NASDAQ:GLPG).

9. Finland

Number of Biotechnology Companies: 120+

Finland is located in Northern Europe. It is one of the most advanced countries in terms of the biotechnology industry. According to rough estimates, the country is home to over 120 biotech companies as of 2021. 

Digital Health happens to be one of the fastest growing sub-industries within the broader sector. Its other strengths are in genomics and clinical analysis. It is largely thanks to the project FinnGen, a government funded project that was intended to obtain the genomic data of 500,000 citizens, 10% of the Finnish population. It is one of the most ambitious projects in the world.

8. Israel

Number of Biotechnology Companies: 160

Israel is located in the Middle East and is the most technologically advanced country in the region. It is home to 160 biotechnology companies as of 2021, according to Jewish Virtual Library. 

Some of the top startups in the country working in the industry include 1E Therapeutics, Future Meat and ReMilk. 1E Therapeutics is developing RNA-oriented treatments against various diseases. As of 2021, the startup has received $120 million in seed investments, as reported by Labio Tech. 

The other two — Future Meat and ReMilk — are working on developing lab meat and sustainable milk (using genetically modified yeast) respectively.

7. United Kingdom

Number of Biotechnology Companies: 415

The United Kingdom is the seventh on the list of most advanced countries in biotechnology. Around 415 Biotech companies are of British origin in Europe according to McKinsey. Between 2018-2020, 22 new biotechnology companies were founded in the country. 

It is one of the top three European countries with companies that are pursuing novel biotechnological solutions in areas like immunotherapy. Biotech startups in the country have an easier time securing early-stage funding than other countries in Europe but the UK lags behind China and the US in the average amount, by $25 million and $15 million, respectively. 

Some of the biotech startups to watch for in the country include Genomics, Healx and Bit Bio. Genomics is working in genomic-sequence analysis and interpretation and has secured $71 million in funding. Healx is another startup in the genomics domain, with $68 million in funding.  Bit Bio, on the other hand, is working in cell therapies and has $50 million in funding as of 2020. 

Apart from its own corporations and startups, the UK also hosts many global corporations like Merck & Co., Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), Eli Lilly and Company (NYSE:LLY), argenx SE (NASDAQ:ARGX), Novo Nordisk A/S (NYSE:NVO), BioNTech SE (NASDAQ:BNTX) and Galapagos NV (NASDAQ:GLPG).

6. Singapore

Number of Biotechnology Companies: 350+

Singapore is a city state located in Southeast Asia. The country is home to over 350 biotechnology companies as of 2022. Some top companies include Tessa Therapeutics, Biosensors and AUM Biosciences. 

However, they’re not quite as big in scale as global companies like Eli Lilly and Company (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), Merck & Co., Inc. (NYSE:MRK), Pfizer Inc. (NYSE:PFE), argenx SE (NASDAQ:ARGX), BioNTech SE (NASDAQ:BNTX) and Galapagos NV (NASDAQ:GLPG)

The top startups in Singapore include Holmusk, ETBio, CoFormula and Kinnva. Singapore’s biotech R&D is highly impactful, primarily due to its world-renowned high quality educational institutes. For a country with a population of only 5.4 million in 2021, Singapore received over 2,000 patent applications in the same year from its residents.

Click to continue reading and see 5 Most Advanced Countries in Biotechnology.

Suggested articles:

Disclosure: none. 12 Most Advanced Countries in Biotechnology is originally published on Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.